A qualitative meta-synthesis of facilitators and barriers to tuberculosis diagnosis and treatment in Nigeria by Zarowsky, C et al.
RESEARCH ARTICLE Open Access
A qualitative meta-synthesis of facilitators
and barriers to tuberculosis diagnosis and
treatment in Nigeria
Charity Oga-Omenka1,2,3* , Lawrence Wakdet4, Dick Menzies3,5 and Christina Zarowsky1,2,6
Abstract
Background: Despite progress in tuberculosis (TB) control globally, TB continues to be a leading cause of death
from infectious diseases, claiming 1.2 million lives in 2018; 214,000 of these deaths were due to drug resistant
strains. Of the estimated 10 million cases globally in 2018, 24% were in Africa, with Nigeria and South Africa making
up most of these numbers.
Nigeria ranks 6th in the world for TB burden, with an estimated 4.3% multi-drug resistance in new cases. However,
the country had one of the lowest case detection rates, estimated at 24% of incident cases in 2018 - well below
the WHO STOP TB target of 84%. This rate highlights the need to understand contextual issues influencing
tuberculosis management in Nigeria. Our synthesis was aimed at synthesizing qualitative evidence on factors
influencing TB care in Nigeria.
Methods: A three-stage thematic meta-synthesis of qualitative studies was used to identify barriers and facilitators
to tuberculosis case finding and treatment in Nigeria. A search of eleven databases was conducted. The date of
publication was limited to 2006 to June 2020. We analyzed articles using a three-stage process, resulting in coding,
descriptive subthemes and analytical themes.
Results: Our final synthesis of 10 articles resulted in several categories including community and family
involvement, education and knowledge, attitudes and stigma, alternative care options, health system factors
(including coverage and human resource), gender, and direct and indirect cost of care. These were grouped into
three major themes: individual factors; interpersonal influences; and health system factors.
Conclusion: Case finding and treatment for TB in Nigeria currently depends more on individual patients presenting
voluntarily to the hospital for care, necessitating an understanding of patient behaviors towards TB diagnosis and
treatment. Our synthesis has identified several related factors that shape patients’ behavior towards TB
management at individual, community and health system levels that can inform future interventions.
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Background
Tuberculosis (TB) remains a global leading cause of
death from a single infectious disease, infecting 10 mil-
lion and killing an estimated 1.2 million people in 2018
[1]. It is caused by the bacillus Mycobacterium tubercu-
losis, and spread through minute droplets produced
through coughing or sneezing [2, 3]. It typically affects
the lungs (pulmonary TB) but can also affect other sites
(extrapulmonary TB) [1]. People infected with the hu-
man immunodeficiency virus (HIV) are more prone to
TB disease due to a weakened immune system [1, 4].
The risk of developing TB is 19 times higher for people
living with HIV than in those HIV negative [1].
Some strains of TB have been resistant to first-line
anti-TB medications, namely rifampicin or isoniazid.
Drug resistant (DR-) TB therefore requires lengthy treat-
ment with multiple, potentially toxic drugs that are up
to five times costlier, and results in poorer treatment
outcomes [1, 5–7]. Much of DR-TB results from
human-made errors including poor management of
drug-susceptible (DS-) TB infections, delayed, inad-
equate access or substandard TB medications, or poor
adherence [8, 9]. DR-TB, estimated at 4.3% of new cases,
was estimated to have claimed 214,000 lives in 2018 [1].
The mixture of high incidence rates of both TB and HIV
infections in sub-Saharan Africa adds new levels of com-
plications to diagnosis, emphasizing the need for coordi-
nated and effective control strategies [1, 10].
TB case detection and access to medications are
proven interventions in reducing the TB burdens of
countries and are critical to meeting the global strategies
to end TB. Several global initiatives have set targets
towards ending the TB epidemic by 2030 [1, 11]. In
September 2018, the United Nations held its first high-
level meeting on TB with the goal of ending the TB epi-
demic by 2030, in line with the Sustainable Development
Goal (SDG) Target 3.3 [11]. The WHO End TB Strategy
2016–2035 aims to reduce TB deaths by 90%, reduce
new cases by 80% and ensure no family faces catastrophic
costs due to TB [1]. The 90–90-90 Stop TB target aims to
reach 90% of all people with TB, 90% of key populations
while keeping a 90% treatment success rate [1].
In Nigeria, TB is a major public health problem. The
WHO estimated the burden of TB in Nigeria in 2018,
with 429,000 incident cases, to be the highest in Africa
(and 6th highest globally) and resulting in 157,000
deaths [12]. However, the 2018 case notification and
treatment rates for all forms of TB at only 24%, were
among the lowest in the world [12]. Lack of access to
healthcare and failure of healthcare workers to recognize
symptoms and test for TB in patients are among some
of the reasons for underdiagnosis of TB [1]. Additionally,
a survey of TB patients in Nigeria revealed one of the
highest catastrophic health costs (71%) among other
high burden countries, mostly due to direct non-medical
costs (transportation, lodging, and nutritional supple-
ments) [1]. All these factors point to significant barriers
in access to diagnosis and treatment in Nigeria, even
though diagnosis and treatment for all forms of TB is
provided for free [13].
The Nigerian TB Control Program has declared find-
ing the missing TB cases as the most important priority
for TB control for the upcoming years [14]. In order to
meet any of these targets, there is an urgent need to
understand contextual issues influencing TB manage-
ment in Nigeria [1, 14, 15].
Several studies from Nigeria have identified barriers
to TB care access [16–19], with only a few using
qualitative design. The use of qualitative research is
particularly necessary to thoroughly understand the
contexts, complex relationships and patterns at play
[20] at the different points in a patient’s pathway to
TB care, as well as the perspectives and behaviors of
patients and health providers and the complex rela-
tions in health care systems, and how these constitute
barriers to TB diagnosis and treatment [21, 22]. A
synthesis of qualitative research is useful in exploring
questions about why interventions work or do not,
and in what context; what the barriers and facilitators
are to accessing health care and the impact of these
on people, their behaviors and experiences [23]. In
order to understand the contextual factors that influ-
ence access to care, there is a need to bring together,
summarize and explore new meanings from the avail-
able qualitative data [24–26].
Our systematic review of qualitative studies explores
the barriers and facilitators of TB healthcare in Nigeria
using a meta-synthesis approach [27]. The research
question guiding this meta-synthesis is: What does
qualitative research tell us about the barriers and facilita-
tors to TB care in Nigeria?
Methods
Overview
Our thematic synthesis explored barriers and facilitators
to TB programs at the individual, community and at the
health system levels [28, 29]. The steps in a meta-
synthesis involve identifying the research question and
relevant studies, appraising the studies for quality and
synthesizing the studies [30]. After the process of litera-
ture selection and quality assessment, this study applied
a thematic approach to qualitative meta-synthesis, as de-
scribed by Thomas and Harden [27]. The thematic syn-
thesis is applied in three steps beginning with the
creation of codes from the original study findings, fur-
ther organization into descriptive subthemes and finally
development of analytical themes [27, 31].
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Step 1: identifying the research question
Our research question aligns with the operational and
public health research priorities of the WHO Inter-
national Roadmap for TB Research and the Nigerian TB
Program to target barriers in the scale up of TB diagno-
sis, treatment and care [14, 32, 33]. The WHO identified
these priorities through review of evidence, expert meet-
ings and consultations with stakeholders and working
groups of the Stop TB partnership [32].
The research question was framed using the SPIDER
approach as recommended by Cooke et al. [34]:
 Sample: Tuberculosis patients in Nigeria
 Phenomenon of Interest: Access to diagnosis and
treatment of TB
 Design: Meta-synthesis of research using interviews,
focus group discussions, observation, in-depth or
key informant interviews
 Evaluation: The reported barriers and facilitators
 Research type: Qualitative research
Our SPIDER-generated research question: What does
qualitative research tell us about the barriers and facili-
tators to diagnosis and treatment access for TB patients
in Nigeria?
Step 2: data sources and identification
We created a search strategy by identifying four key
themes in the research question: tuberculosis, access,
qualitative and Nigeria. Search terms and variations were
generated based on the themes. These can be seen in
the Table 1: Medline Search Strategy.
Eleven databases searched were searched- Medline,
Scopus, EBM Review, Web of Science, Pubmed, Embase,
CINAHL, Global Health, African Journal Online (AJOL),
the International Journal for TB and Lung Disease
(IJLTD) and Google Scholar. A reference list search for
included studies did not yield any additional studies.
Search results were exported to EndNote®. The date of
publication was limited from January 2006 (2006 being
the first publication year for the WHO Guidelines for
the programmatic management of drug-resistant tuber-
culosis) to the date of search, which was 18th of August
2018. The search was rerun on the 30th of June 2020.
There were no language restrictions.
Step 3: study selection and quality assessment
The citations imported into Endnote® were screened in a
stepwise approach starting with removal of duplicates,
followed by the review of titles, abstracts, and finally the
full text based on the inclusion and exclusion criteria.
This process is shown in Fig. 1.
Inclusion criteria
 Studies focusing on case finding and treatment of
TB in Nigeria
 Studies published from 2006 to June 2020
 All languages
Exclusion criteria
 Abstracts without full texts
 Focus outside Nigeria
 Not peer reviewed
 Absence of qualitative data
A quality assessment was performed independently by
two authors (COO and LW), using the simplified criteria
for qualitative research, recommended by Murphy et al.
[35]. This involved two initial criteria and seven screen-
ing questions to determine the credibility and relevance
of the studies [35, 36]. Results of the quality assessments
were discussed, and differences resolved by consensus.
Table 1 Medline Search Strategy
1 Tuberculosis, Pulmonary/ Or Mycobacterium tuberculosis/ Or Tuberculosis/ Or Latent Tuberculosis/ Or Tuberculosis, Multidrug-Resistant/ Or
Extensively Drug-Resistant Tuberculosis/
2 limit 1 to yr = “2016 -Current”
3 (delay or barrier or diagnostic error* or access or late).mp. [mp = title, abstract, original title, name of substance word, subject heading word,
keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms]
4 limit 3 to yr = “2016 -Current”
5 (qualitative or interview$ or focus group$ or phenomenology or ethnograph$ or grounded theory or observation$ or field stud$ or case
stud$).mp. [mp = title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary
concept word, rare disease supplementary concept word, unique identifier, synonyms]
6 limit 5 to yr = “2016 -Current”
7 NIGERIA/
8 limit 7 to yr = “2016 -Current”
9 2 and 4 and 6 and 8
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Step 4: thematic synthesis
As described by Thomas and Harden, the process of a
thematic synthesis has three stages – free line-by-line
coding of the text within the ‘Results’ sections of the
primary studies, creation of descriptive subthemes by
organizing the codes into related areas, and finally, the
generation of analytical themes across the set of retained
studies [27]. The descriptive subthemes are similar to
that found in the primary studies, but the analytical
themes represent the new interpretation generated from
those [27, 31, 37]. All texts of results were read, line
after line, and the content of each text fragment inter-
preted. All sentences were then copied into the Quirkos
database, except for one, [38], which examined commu-
nity initiatives for health interventions and not just for
TB. For this, only sections within the results that were
relevant for TB disease were selected. The next step was
a sentence-by-sentence coding base on meaning and
content, with some sentences getting more than one
code. This process resulted in a total of 21 initial codes.
The process of developing the descriptive subthemes
involved looking at the similarities and differences between
the codes and grouping them into a hierarchical tree struc-
ture. New terms were used to describe the meanings and
contexts of groups of initial codes. This process resulted in
a hierarchical structure with a total of 11 descriptive sub-
themes. Three analytical or ‘higher order’ [39] themes were
created by interpreting the relationships between themes
across studies and in relation to the research question. This
was done using the Quirkos software.
Results
Study characteristics
There were 10 studies from Nigeria that explored factors
that impact access to TB care from a qualitative perspec-
tive, 9 qualitative studies and 1 mixed method. The
characteristics of the 10 studies synthesized are pre-
sented in Table 2.
A variety of methods were used in data collection in-
cluding in-depth interviews, focus group discussions,
semi-structured interviews and key informant interviews.
Sample size ranged from 24 to 221.
Fig. 1 PRISMA Diagram of Selection Process
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The ten studies differed in focus even though all dir-
ectly or indirectly explored factors influencing diagnosis
and treatment to care- including barriers to direct ob-
servable treatment short course (DOTS), the WHO en-
dorsed system of TB care [40, 43, 44, 48]; the role of
family members [41, 44, 46, 47], patent medicine ven-
dors (PMVs) [45] and treatment supporters [43]; par-
ticular focus on gender-based factors [46], care pathways
[44], challenges of drug-resistant TB care [41] and TB/
HIV co-infection [47]; as well as community-level inter-
ventions with some particular reference to TB [38].
Quality assessment
The quality assessment for the selected studies are pre-
sented in Table 3. Three out of ten studies were classi-
fied as “A”, and the remaining 8 classified as “B”, using
the Murphy criteria [35].
Description of themes
Our synthesis yielded three main themes and eleven
inter-related sub-themes (Fig. 2). On the individual level,
financial capacity, education and knowledge, as well as
attitudes and beliefs were facilitators or barriers. On the
Table 2 Overview of selected studies
First Author,
Year





Challenges of Tuberculosis Control in
Lagos State, Nigeria: A Qualitative







Challenges with TB management and
supervision, laboratory tests, DOTS
providers’ training, and work overload
2 Ajayi,
2013 [38]
Assessing resources for implementing
a community directed intervention
(CDI) strategy in delivering multiple
health interventions in urban poor










Community resources can facilitate
access to health care
3 Bieh,
2017 [41]
Hospitalized care for MDR-TB in Port
Harcourt, Nigeria: a qualitative study











Through service providers’ eyes: health
systems factors affecting
implementation of tuberculosis control
in Enugu State, South Eastern Nigeria
23 in-depth interviews
with health workers
Framework approach Leadership and governance, health
financing and human resources, supply
chain system (technology), health
information system and service delivery
5 Olukolade,
2017 [43]
Role of treatment supporters beyond
monitoring daily drug intake for TB-
patients: Findings from a qualitative
study in Nigeria




Patient nominated treatment supporter




Barriers to care seeking in directly
observed therapy short-course (DOTS)
clinics and tuberculosis control in




developed in the form
of codes and further
summarized ethno-
graphically
Perceived causes of TB infection,
perceived high costs & quality of care




Is there a role for patent medicine







Knowledge and practice about TB,
referral practices, awareness of TB
clinics, involvement in detection of TB
cases and attitudes towards




women’s health seeking for
tuberculosis care in Ebonyi state,
Nigeria
56 interviews – with





Socio-cultural & economic factors
weaken women’s access to health care
9 Ushie,
2012 [47]
The paradox of family support:
Concerns of tuberculosis-infected HIV
patients about involving family and
friends in their treatment.
8 FGD, 21 In-depth
Interviews,
4Case histories
Thematic analysis Family support promotes adherence
10 Ukwaja et al.
(2017) [48]
Sustaining the DOTS’: stakeholders’
experience of a social protection
intervention for TB in Nigeria.
103 key Informant





Patients and health workers recorded
positive outcomes with financial
inducements
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interpersonal level, family influences and community in-
volvement were facilitators, while negative community
attitudes and beliefs, especially towards public sector TB
care, and harmful gender norms, were barriers. At the
facility level, cost of service, human resource and cover-
age and type of services were either facilitators or bar-
riers. We also discuss the stage of care - diagnosis or
treatment – the access factor was more prevalent.
Each of the three themes are presented in more detail
below.
Individual factors
This theme reflects the individual-level factors that de-
termine the use of healthcare. It emanated from three
descriptive subthemes of financial capacity, education
and knowledge, attitudes and beliefs.
Cost of treatment, particularly indirect costs such as
relating to transport or additional fees, were cited by
participants as a major barrier to both diagnosis and
treatment. For example, one participant in the Oshi
et al., 2016 study stated that “There are very few women
in my community who can afford the costs of transporta-
tion to the hospital and to pay the hospital fees. Maybe
the traders! Even then, if they are not cautious taking
money from their business to go for treatment will spoil
[ruin] their business...” (Interview with 29 years old fe-
male with secondary education) [46]. In a different study
[38], a participant discussed mentioned how “Many
women go to faith healers now not because they do not
know that it is better to have treatment in the hospital,
but because they cannot afford it. Many of our women
are not employed …” [38].
Table 3 Quality Assessment
Study Credibility Relevance Score
Data collection Auditability Reflexivity Negative cases Fair dealing Transferability Analytic generalization
Adejumo 2020 [40] x x x x B
Ajayi 2013 [38] x x x x x x A
Bieh et al., 2017 [41] x x x x x x A
Ogbuabor 2020 [42] x x x x x B
Olukolade et al.,
2017 [43]
x x x x B
Okeibunor et al.,
2006 [44]
x x x x x B
Onyeneho 2010 [45] x x x x x B
Oshi et al., 2016 [46] x x x x x B
Ushie & Jegede
2012 [47]
x x x x x B
Ukwaja et al
2017 [48]
x x x x x x A
1-2 points = C, 3-5 points = B and 6-7 points = A
Quality assessment questions
Credibility
Data collection • Were explanations of sampling strategies and data collection methods provided?
Auditability • Was the method of data analysis described and enough data displayed to allow the reader to determine whether the
interpretations made by the researcher is supported by the data?
Reflexivity • Did the authors acknowledge the influence of the research process and the presence of the researcher including the
role of prior biases, assumptions and experience, on the collected data?
Negative cases • Has appropriate attention been given to contradictory data? Are negative cases taken into account?
Fair dealing • Did the authors explore alternative, plausible explanations for the data collected and incorporate a range of different
perspectives?
Relevance
Transferability • Did the authors provide information regarding participants, setting and context so that the reader might be able to
determine the relevance of the findings to other settings (transferability)?
Analytic
generalization
• Did the authors discuss findings within a broader context, propose generalization of findings and/or suggest a
direction for future research?
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However, patients who received family support, as
discussed below, were better able to mitigate the cost
barrier.
Several codes were related to the patient’s education and
knowledge. Participants noted that attitudes and beliefs hin-
dered correct diagnosis. Knowledge about the cause of TB
or the availability of free care, negative perceptions of public
sector care or a preference for alternative care in the private
sector were recurring barriers to diagnosis.
“It is only a prophet who can destroy the powers of
the witch. So, such persons who have TB can only be
cured through prayers by powerful prophets” (41
years old female, uneducated farmer) [46].
‘It took some time before I went to get drugs for this
illness... I went to two prayer houses yet I did not
get better ...so I started taking herbal treatment’
(FGD, 42-year-old male) [48].
For some patients, the use of alternative treat-
ments, or the reason for delayed care-seeking were
due to financial constraints. This was a particular
barrier to diagnosis.
Fig. 2 Diagram showing barriers and facilitators associated with each theme and subthemes
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“For the first two months when I started coughing, it
was very hard for me because I had no money to go
to the chemist... even after I visited the chemist and
got some drugs the cough persisted” (FGD, 65-year-
old male) [48].
“I did not have any money to buy drugs when my
illness started...so I started taking herbal remedies”
(FGD, 58-year- old female) [48].
Some of the themes were inter-related, for example
uneducated patients were more likely to delay treatment
in favor of prayer houses and traditional healers.
“Health seeking depends on the level of education.
The [uneducated] would delay going to hospital.
They first use local herbs.” “Patients first move to
chemists and herbalists and finally hospital if they
cannot get cure from these sources. Where they go
first depends on whether they believe TB is man-
made, natural, or caused by witchcraft.” [44].
A few patients complained about the fact that most
available health resources in their immediate localities
were focused on pregnant women and children, alienat-
ing males and other women. This perception of public
healthcare could have been a barrier to diagnosis, espe-
cially for males.
“All the health programmes in this community are
designed for women and children. Is there nothing
that can be done for adult males and females? If we
are sick and not treated, we will transfer the sickness
to the children [38].
Interpersonal influences
This theme refers to the effect of the family and commu-
nity on the decision-making processes of people in need
of care, ranging from codes on stigma and discrimin-
ation to community awareness campaigns. It is also
reflected in the extent of deference women were ex-
pected to have towards their husbands when it came to
health seeking decisions.
Factors like stigma and discrimination affected women
differently from men, as some participants were quoted
saying a female TB patient would be a pariah and would
be unlikely to get suitors or could possibly be divorced
as a result of her illness. Also, a husband who attribute
TB to other causes or who have negative perceptions
about its management could potentially prevent his wife
from accessing care. These gender norms were men-
tioned by different participants. One participant said,
“Women should be submissive to their husbands. A
woman who knows more than her husband portends
danger to the community. If a man says the medicine is
good, then it is good. If he says the medicine is not good,
who is the wife to disagree.” (elderly, female, farmer)
[46]. Another mentioned that, “… The ability of a
woman to pay for hospital treatment does not mean that
she can just get up and go to the hospital without her
husband’s permission.” [46]. In another study, a partici-
pant mentioned that marriages were breaking up be-
cause of one partner’s infection. “The community leader
… argued that traditionally, infection with TB is not
grounds for divorce, but spouses often cloak the real rea-
son for seeking separation.. .” [44].
On the other hand, family and community support
were facilitators to initiating and adhering to treatment.
This support was sometimes financial and this enabled
patients to continue accessing treatment.
“For me it was very traumatic to start taking
drugs I have not been used to... but I got so many
encouragements, people around me, .... And probably
to be frank, if not for their own encouragement and
everything, I would have stopped; because this is my
last month, I wouldn’t have taken it this far, I would
have stopped, but they encouraged me that I had to
complete the period of medication” Female TB
Patient, Asokoro [43].
“My son and wife have been very helpful...they
accompany and support me to go to the clinic and
to take my drugs” (IDI, 50-year-old male) [48].
“Whenever I am seating lonely and quiet, my
husband usually comes to me and asks: ‘why am I
seating quiet, am I alright? And whenever my drugs
are finished, he goes and gets them for me and he
advises me to take the drugs”, Female TB Patient
Interview, [43].
“My difficulty is getting transportation to get to this
place (DOTS centre). I will go and meet my brother
to tell him that I am supposed to go and take drugs
then he will find me some money for transportation”,
Male TB Patient [43].
For some, having a knowledgeable person in the commu-
nity, sometimes healthcare workers, direct them to the right
public facility for TB care were facilitators of diagnosis.
“I visited all the chemists in my community and took
several medication, yet the cough kept increasing...I
visited the health centre twice before the nurse said I
may have TB I should come to this hospital” (IDI,
35-year-old female) [48].
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Health system factors
Health system barriers were a recurring theme in all the
studies. They emerged from codes around poor coverage
of services, weak referral system, low numbers and poor
skills in health workers, poor attitude of staff and quality
of care, corrupt staff demanding illegal charges from pa-
tients and the relatively high cost of patient cards. These
codes were grouped into three descriptive subthemes-
coverage and type of services, human resource, and cost
of service.
Coverage and opening hours were cited as barriers,
mostly to diagnosis but sometimes in relation to treat-
ment access.
“If they [hospitals] want to help us they should make
their opening hours flexible so that we [women] can
also go there in the evening hours, after the days’
work. That will be more convenient for women.” [46].
Poor coverage was also linked to high transportation
costs and the reason why patients were choosing alterna-
tive care in the private sector. These were mostly barriers
to diagnosis.
“There is no general hospital around. The nearest
one … is far from here. Many people don’t want to
go there because of cost of the transportation and
services. People treat themselves at home or go to
herbalists. Only very few people go to private
hospitals as they are very expensive [38].
The attitude of healthcare workers created barriers to
diagnosis for a number of patients. This was a recurring
theme across several studies. One participant said, “Even
some nurses and medical workers treated us like we are
not fit to live again. They keep a distance when they
want to communicate with us. If you come closer, they
will shout go! go!! go!!! ........ The feeling of stigma is very
difficult. I felt like the worst person on earth having
MDR-TB” (IDI, 29 years old male [41]. A healthcare
worker in another study confirmed this discriminatory
treatment of patients, “…. I have been sending my pa-
tients for a laboratory test at a particular hospital, but
she refused to go because of the way she was treated the
last time she went. I decided to visit the place myself to
see with my eyes what was going on. You cannot imagine
what I saw. Immediately they (the health workers) saw
me approaching them, they shouted at me to go back as I
walked in not knowing I am a DOTS Provider. I can
imagine what the patients go through ….” (DOTS Pro-
vider) [40].
Healthcare workers, on their part, complained of
shortage of workers, unbearable workloads, inadequate
training and a lack of laboratory resources. These
challenges were mostly barriers to diagnosis, and some-
times to treatment as well.
“… For me as an example, I am the clinician in my
facility. I am expected to go on outreach [es],
consultation of patients that come to my facility is
my responsibility. I am the DOTS provider. I used to
have 22, now I have 27 centers under me to
supervise. Then how do I share myself, …” (TB
Supervisor) [40].
“My workload is high. It is not only TB services that
I provide. I am also the anti-retroviral therapy focal
person” [42].
Patent medicine vendors are readily available in
the communities and see a lot of clients with
coughs. However, many PMVs were not trained on
TB control nor were aware of TB DOTS centers but
were overwhelmingly eager to be part of the TB
control effort [45]. The use of alternative care in the
private sector was always a barrier, due to the poor
linkage between the public and private sector. Sev-
eral reasons contributed to the use of the PMVs and
some of these linked back to individual factors. They
included poor coverage of health services, patients in
geographical locations with poor accessibility where
only PMVs were available, perceived high costs of
care in the public sector, even though TB services
were supposedly free.
“Patent medicine vendors are the main source of
healthcare service delivery in this community. Many
people go to PMVs because medicines are not readily
available at the health centres and if available, they
are costlier because patients have to pay for other
services such as a consultation when they go to the
hospital” [38].
“We are in the local communities, a very interior
part of the community, and we deal with people of
the local communities; hence, such people come to
the patent medicine shop to re- quest, “sir, do you
have something like this” (PMV practitioner) [45].
Some of the PMVs were not aware of how to diagnose
TB or the availability of free TB services in the public
healthcare system.
“… I have not heard about it (DOTS clinic). I am
not aware of DOTS clinic but if it is evolved, it will
help in the control of people with tuberculosis in our
environment” Interview with an official of a local
PMV association [45].
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“They (PMVs) should be informed, involved, educated,
and trained.... You will know what you have learnt,
and if anything comes up, you will tell the person”
(PMV leader) [45].
Other factors that were mentioned include absence of
doctors at community levels and illegal charges
demanded from patients. Several patients alleged that
healthcare workers were diverting free medications from
the TB centres to their private health centres, where
they now charge the patients. As this was mainly from
one article, we were not able to ascertain if this problem
was widespread.
“Attitude of health workers, cost and distance are
the issues here. Health workers at the DOTS clinics
can hardly be seen, sometimes for a month or more.
The health workers have their private Chemists/
consulting shops where they treat their private
patients. They sometimes divert clinic resources
for that purpose” (FGD with women) [44].
“Health workers at DOTS clinic, all have consulting
shops outside the hospital. Drugs are not free. Attitude
of health workers toward patients is influenced by
amount of money the patient has” (FGD with
men) [44].
Key facilitators included the financial support provided
to the patient by the program.
“I thank you for providing us this money...most times
when I want to come to the hospital I borrow money
for transportation then when I collect the money I
will go and pay back” (IDI, 45-year-old female) [48].
Discussion
This meta-synthesis looked at barriers and facilitators to
TB diagnosis and treatment in Nigeria and resulted in
three major themes, centered on individual, interpersonal
influences, and health systems factors. These themes were
common across different studies, irrespective of type of
study and data collection method. They were also inter-
related even though presented here separately. The find-
ings of this synthesis are in line with several other studies,
within and outside Nigeria.
For example, studies on TB control in Nigeria show
operational challenges occurring at patient and health
system levels. Reported barriers include beliefs about
causes of TB, knowledge of treatment duration and ben-
efits, socioeconomic status, literacy, stigma, hidden treat-
ment costs, distance from the clinic, access to health
care, and health worker attitude and knowledge [17, 49].
Specifically, other studies and reviews, including from
elsewhere in Africa, identify patient level barriers as cost
of care, fear of stigma, distance from facility, worsening
disease, inadequate knowledge about the disease, and
perceptions of poor quality of care at hospitals [50–55].
Facilitators to patient TB care-seeking behavior have
been identified in literature as knowledge of TB and
HIV disease and treatment [54, 56].
At the community level, other studies also identified
awareness and screening campaigns as facilitators [56–58].
These agree with findings of studies from several African
studies in Zimbabwe, Malawi and Ethiopia, where active
case finding in the community, e.g. using mobile vans to be
very effective even in communities in close proximity to a
hospital [59–64].
At the health system level, barriers like poor tracking
of patients, delays in access to testing, staff shortages
and work overload/overtime, inadequate health worker
knowledge of transmission, misdiagnosis, poor infection
control, staff shortages, overwhelming workloads, add-
itional testing required and lengthy triage procedures
have been identified [51–53, 56, 57, 65–68].
On the other hand, facilitators in health systems are
patient financial support, quick testing time, appropriate
counseling and testing, patient tracking, health worker
training, quick and efficient workflows, sufficient staff-
ing, free and confidential TB services [50, 51, 54, 56,
57, 69–71].
Authors of selected articles made several recommen-
dations for tackling identified barriers. These included
training, supervision and logistical support for healthcare
workers, as well as resource mobilisation and hiring of
new health workers [40, 42, 44]; training and engage-
ment of patent medicine dealers by the National TB pro-
gram [45]; financial, family and community support, as
well as home-based care wherever possible for patients
[38, 41, 43, 47, 48]; women empowering policies, pro-
grammes and interventions targeting harmful gender
norms with the aim of increasing women’s access to TB
services [46].
Meta-synthesis limitation
The main limitation of our study is that we chose to in-
clude most of the studies that met our inclusion criteria,
sometimes in spite of quality, and low methodological
rigor. This was done to include as much available data
as possible, due to a low availability of qualitative re-
search on barriers to TB care from Nigeria. As a result
of this, the identified themes are subject to the limita-
tions, rigor and quality of the original articles. This may
limit the transferability of our findings. However, we
ensured that all selected studies had relevant data on
barriers to TB care in Nigeria. Another limitation is the
sparsity of data relating to several aspects of TB care
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identified in literature as being more difficult, including
pediatric or drug-resistant TB diagnosis and treatment.
Conclusions
This synthesis highlights a number of factors influencing
access to diagnosis and treatment of TB in Nigeria,
including attitudes and beliefs, financial capacity, educa-
tion and knowledge on the individual level; community
attitudes and beliefs, family influences, including nega-
tive gender norms, community involvement and private
sector care on the community level; and coverage, hu-
man resource and cost of service on the health system
level.
Based on these findings, interventions are needed to
improve case finding, for example, increasing patient
education and community awareness to modify harmful
perceptions on TB disease and management. This could
potentially improve diagnosis and treatment rates by re-
ducing the time and expenses spent by patients seeking
care outside facilities equipped to diagnose and treat TB
cases in Nigeria. Also, measures are needed to improve
health worker attitudes and the quality of care they
provide.
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